Selective degradation of proteins
AssigneeSyntheX, Inc.
InventorsCharly Chahwan, Maria Soloveychik
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntheX, Inc.
InventorsCharly Chahwan, Maria Soloveychik
Estimating the term…
The present disclosure provides methods to identify peptides and small molecule moieties that are able to functionally bridge an interaction between a target protein and an E3 ubiquitin ligase to mediate the degradation of the target protein. Some moieties can degrade specific target variants, but not others. The moieties create a neosubstrate for an E3 ligase of interest. The methods described enable generation of compounds able to selectively degrade specific targets within cells with implications for drug development for pathological conditions. The disclosure also describes the generation of modified peptides using post-translational modification enzymes, such as N-methyltransferases, prolyloligopeptidases, lactamases, hydroxylases, and dehydratases, along with methods of using the same.
A host cell comprising DNA encoding:
Dependencies are inferred from the claim text.